Patent Assignment
Reel/Frame 063027/0171
Assignment of Assignor's Interest
Recorded: 2023-03-19
Pages: 3
Assignor
SOMBERG, JOHN
Executed: 2023-03-09
Assignee
HYLORIS DEVELOPMENTS SA
BOULEVARD OF PATIENCE ET BEAUJONE, NO3/1, LIEGE, 4000, BELGIUM
Covered Properties
(3)
Intraveneous Dofetilide to Reduce the Risk of Developing Af/Afl Post Coronary Bypass Surgery
Intraveneous Dofetilide to Terminate Arrhythmic Storm Following Implantation of a Cardiac Defibrilator
Application:
18/175,971 →
Publication:
US 2024/0285558
Intravenous Dofetilide to Convert Atrial Fibrillation/Flutter